Shares of Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA – Get Free Report) have been assigned an average rating of “Hold” from the six ratings firms that are covering the stock, Marketbeat reports. One research analyst has rated the stock with a sell rating, three have assigned a hold rating and two have given a buy rating to […]
Enanta Pharmaceuticals (NASDAQ:ENTA) Stock Rating Upgraded by StockNews.com dailypolitical.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailypolitical.com Daily Mail and Mail on Sunday newspapers.
Enanta Pharmaceuticals (NASDAQ:ENTA – Get Free Report) was downgraded by research analysts at StockNews.com from a “hold” rating to a “sell” rating in a research note issued on Saturday. Separately, JPMorgan Chase & Co. decreased their target price on shares of Enanta Pharmaceuticals from $12.00 to $11.00 and set an “underweight” rating on the stock […]
Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA – Get Free Report) has been given an average recommendation of “Hold” by the six ratings firms that are presently covering the stock, MarketBeat.com reports. One investment analyst has rated the stock with a sell recommendation, three have assigned a hold recommendation and two have issued a buy recommendation on the […]
Enanta Pharmaceuticals (NASDAQ:ENTA) Upgraded at StockNews.com kopsource.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kopsource.com Daily Mail and Mail on Sunday newspapers.